Abbott Laboratories
NYSE:ABT
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
US |
Abbott Laboratories
NYSE:ABT
|
197.1B USD | 9.2 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
140.6B USD | 28.6 | ||
US |
Stryker Corp
NYSE:SYK
|
136B USD | 11 | ||
IE |
Medtronic PLC
NYSE:MDT
|
115.9B USD | 6.2 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
100.4B USD | 10.9 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
71.5B USD | 10.5 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
63.3B EUR | 9.4 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
57.4B USD | 12.2 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
53.5B USD | 23.1 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
339.1B CNY | 14.4 | ||
US |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.8B USD | 20.7 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.